J3305 Trimetrexate Glucuronate - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Trimetrexate Glucuronate

Brand Name:

Trimetrexate Glucuronate

Strength:

per 25 mg

HCPCS:

J3305

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Folic Acid Antagonist

Oral (Y/N):

No

FDA Approval Year:

1993

FDA Discontinuation Year:

2007

CMS Effective Date:

Jan. 1, 1996

CMS Discontinuation Date:

Status:

In Use